ShallowBench: Benchmarking Generative Drug Design Models on Shallow-Pocket Targets
Researchers introduce ShallowBench, a curated benchmark of 5,780 shallow-pocket protein targets, revealing that current generative AI drug design models struggle with low-concavity binding sites common in challenging oncology targets like KRAS and MYC. The benchmark highlights a critical gap in generative biology that requires new architectural innovations to address historically undruggable targets.